MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Discrepancies in postural stability outcomes measured by computerized dynamic posturography and functional balance assessments in Parkinson’s Disease

    E. Doctor, R. Bliss, J. Kanaley (Columbia, USA)

    Objective: To determine ideal assessment for detecting exercise-induced differences in postural stability of individuals with early-stage Parkinson’s Disease (PD). Background: Postural instability (PI) is a…
  • 2022 International Congress

    Cycling Deep Brain Stimulation for Parkinson’s Disease

    C. França, A. Bertholo, A. Pelicheck, I. Paraguay, J. Reis, D. Barros, J. Yamamoto, A. Coelho, R. Otani, M. Reuter, R. Carra, T. Guimarães, M. Teixeira, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: To compare gait disorders in patients with Parkinson's disease (PD) and Deep Brain Stimulation (DBS) using continuous vs cycling (40sec on, 2sec off) stimulation.…
  • 2022 International Congress

    Study of retinal and optic nerve ganglion cell layer in Parkinson’s disease and asymptomatic carriers of the LRRK2-G2019S mutation

    A. Cerveró, A. Sánchez-Rodríguez, M. Rivera-Sánchez, I. Martínez-Rodríguez, M. Sierra, I. González-Aramburu, A. Gutiérrez-González, J. Andrés-Pacheco, A. Casado, J. Infante (Santander, Spain)

    Objective: To study whether retinal nerve alterations can be a useful biomarker in presymptomatic stages of Parkinson's disease (PD) associated with the G2019S mutation of…
  • 2022 International Congress

    Dopaminergic medication improves movement vigour in Parkinson’s but not the adaptation of movement speed to curvature

    L. Hickman, D. Fraser, J. Galea, J. Cook (Birmingham, United Kingdom)

    Objective: This study assessed kinematic profiles of individuals with Parkinson’s on and off dopaminergic medication to investigate whether the effect of dopaminergic modulation on speed…
  • 2022 International Congress

    Polymorphisms in Prosaposin gene are associated with familial and early-onset Parkinson’s disease: A case-control association study and meta-analysis

    YT. Chu, MC. Kuo, YA. Su, RM. Wu (Taipei, Taiwan)

    Objective: To investigate the role of the PSAP gene in PD patients in Taiwan, including familial PD and early-onset Parkinson’s disease. Background: Mutations in the…
  • 2022 International Congress

    Intestinal microbial dysbiosis promotes prebiotic-reversible inflammation in Parkinson’s disease

    R. Manfready, D. Hall, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: To determine the functional effects of disrupted intestinal microbiota in Parkinson’s disease (PD), particularly the impacts of dysbiosis on inflammation, neuroprotective hormone secretion, and…
  • 2022 International Congress

    Design of the Remote Optimization Adjustment and Measurement for Deep Brain Stimulation (ROAM-DBS) Randomized Controlled Trial Using Decentralized Patient Monitoring

    T. Tomlinson, A. Gharabaghi, S. Groppa, L. Luo, H. Lu, M. Feldman, C. Luca, V. Marshall, A. Merola, L. Muñoz-Delgado, A. Schnitzler, L. Verhagen, B. Walter, C. Wu, S. Zauber, L. Zhang, B. Cheeran (Plano, USA)

    Objective: To describe the design of the ROAM-DBS trial which measures outcomes of remote programming using remote monitoring. Background: A third of Parkinson’s Disease (PD)…
  • 2022 International Congress

    ‘Top of the POPPS’ – how we set up an online support group for Partners of People with Parkinson’s.

    E. Edwards, S. Austin, J. Friend (Plymouth, United Kingdom)

    Objective: To provide useful peer and professional support for partners of people with Parkinson's (PWP)To be able to offer that support in a Covid safe…
  • 2022 International Congress

    A qualitative study exploring the treatment burden and capacity of people with Parkinson’s and their caregivers

    QY. Tan, H. Roberts, S. Fraser, K. Ibrahim (Southampton, United Kingdom)

    Objective: To explore experiences of treatment burden and capacity in Parkinson’s and identify potentially modifiable factors that can improve this Background: Treatment burden, the workload…
  • 2022 International Congress

    Lymphocyte count/neutrophil-to-lymphocyte ratio and mild cognitive impairment in Parkinson’s disease

    E. Contaldi, L. Magistrelli, S. Gallo, C. Comi (Novara, Italy)

    Objective: The present study aimed to elucidate whether i) lymphocyte count and neutrophil-to-lymphocyte ratio (NLR) can discriminate Parkinson's disease (PD) patients from healthy controls (HC);…
  • « Previous Page
  • 1
  • …
  • 353
  • 354
  • 355
  • 356
  • 357
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley